Published in J Clin Invest on December 01, 1978
Intracellular degradation of newly synthesized secretory proteins. Biochem J (1983) 1.31
Reference range for serum parathyroid hormone. Endocr Pract (2006) 1.09
Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells. J Clin Invest (1983) 1.07
Secretion and degradation of parathormone as a function of intracellular maturation of hormone pools. Modulation by calcium and dibutyryl cyclic AMP. J Cell Biol (1979) 1.04
Factors that influence the assessment of parathyroid graft function. Ann Surg (1984) 0.82
Parathyroid hormone assay: problems and opportunities. Pediatr Nephrol (2007) 0.79
The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. NDT Plus (2008) 0.78
Effects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rat. J Clin Invest (1981) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY. Science (1964) 4.93
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab (1968) 2.41
Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology (1968) 2.36
Immunogenicity of a series of alpha,N-DNP-L-lysines. Biochemistry (1965) 2.35
Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A (1971) 2.04
Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A (1970) 1.81
Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J Clin Invest (1973) 1.77
Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A (1970) 1.77
Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest (1972) 1.77
Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest (1975) 1.70
Calcium-dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology (1975) 1.37
Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands. J Clin Invest (1977) 1.35
Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest (1975) 1.30
Calcium-regulated parathyroid hormone peptidase. Proc Natl Acad Sci U S A (1972) 1.28
Metabolism of parathyroid hormone: physiologic and clinical significance. Am J Med (1974) 1.25
Isolation and characterization of the bovine parathyroid isohormones. Biochemistry (1971) 1.24
Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. Endocrinology (1971) 1.09
Biosynthesis of proparathyroid hormone and parathyroid hormone by human parathyroid glands. J Clin Invest (1973) 1.03
Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate CA++ concentrations. J Clin Invest (1977) 1.03
Dynamics of parathyroid hormone secretion in vitro. Am J Med (1971) 0.97
The by-pass of tissue hormone stores during the secretion of newly synthesized parathyroid hormone. Endocrinology (1975) 0.97
Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion. J Clin Invest (1976) 0.91
Basal and dibutyryl cyclic AMP-stimulated release of newly synthesized and stored growth hormone from perifused rat pituitaries. Endocrinology (1976) 0.89
Carboxyl-terminal fragments of human parathyroid hormone in parathyroid tumors: unique new source of immunogens for the production of antisera potentially useful in the radioimmunoassay of parathyroid hormone in human serum. J Clin Endocrinol Metab (1978) 0.89
Enzymatic inactivation of parathyroid hormone by rat kidney homogenate. Endocrinology (1970) 0.88
Nature of human parathyroid hormone secreted by monolayer cell cultures. J Clin Endocrinol Metab (1972) 0.86
Emerging concepts of the nature of circulating parathyroid hormones: implications for clinical research. Recent Prog Horm Res (1974) 0.85
New concepts in the formation, regulation of release, and metabolism of parathyroid hormone. Ciba Found Symp (1976) 0.85
Regulation of function of transplanted parathyroid glands in man. Am J Med (1977) 0.85
Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro. J Clin Endocrinol Metab (1977) 0.81
A biologically active hormonal fragment isolated from bovine parathyroid glands (BPTH 1-65). Biochemistry (1975) 0.81
Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol (1988) 5.96
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A (1984) 4.97
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood (1981) 2.53
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
From outcomes research to disease management: a guide for the perplexed. Ann Intern Med (1996) 2.38
Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology (1968) 2.36
Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett (1989) 2.34
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
IgD multiple myeloma. Review of 133 cases. Arch Intern Med (1975) 2.10
Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med (1991) 2.03
Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab (2000) 2.00
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A (1985) 1.86
Transplantation of the parathyroid glands in man: clinical indications and results. Surgery (1975) 1.84
Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem (1997) 1.84
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol (1997) 1.83
Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A (1970) 1.81
Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood (1999) 1.79
HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res (1992) 1.79
Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J (1993) 1.77
Adult T cell leukemia. Histological classification and characteristics. Acta Pathol Jpn (1979) 1.74
Parathyroid hormone: chemical properties and structural requirements for biological and immunological activity. Recent Prog Horm Res (1966) 1.74
Evaluation by radioimmunoassay of factors controlling the secretion of parathyroid hormone. Nature (1966) 1.71
Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. J Immunol (1990) 1.66
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci U S A (1997) 1.65
Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med (1976) 1.64
Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol (1992) 1.59
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood (1996) 1.59
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol (2001) 1.57
Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res (1997) 1.56
Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol (2001) 1.54
Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med (1989) 1.51
Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst (1990) 1.49
Leukaemia of novel gastrointestinal T-lymphocyte population infected with HTLV-I. Lancet (1991) 1.48
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
IgG heavy chain allotypes (Gm) in autoimmune diseases. Clin Exp Immunol (1980) 1.46
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
Role of neutrophils in spinal cord injury in the rat. Neuroscience (1997) 1.45
Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients. Am J Hematol (1993) 1.45
A human T-cell lymphotropic virus type-I carrier with chronic renal failure, aplastic anemia, myelopathy, uveitis, Sjögren's syndrome and panniculitis. Intern Med (1996) 1.43
Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats. Crit Care Med (1997) 1.42
HTLV-I and uveitis. Lancet (1992) 1.38
Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol (1997) 1.36
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia (2000) 1.36
Interleukin 1 gene expression in adult T cell leukemia. J Clin Invest (1987) 1.36
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int (2010) 1.34
Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology (1983) 1.34
A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-alpha-trypsin inhibitor. Int Immunol (1989) 1.31
Letter: Two cases of T-cell chronic lymphocytic leukemia in Japan. N Engl J Med (1974) 1.30
Perfusion of the isolated parathyroid gland of the goat and sheep. Nature (1966) 1.29
Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood (1987) 1.29
Thyroid cancer incidence. Nature (1992) 1.29
Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology (1986) 1.29
Human prolactin. N Engl J Med (1971) 1.28
Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med (1982) 1.27
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology (1985) 1.25
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med (1976) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int (2010) 1.24
A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases. Blood (1983) 1.22
Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood (1996) 1.21
Modulation of Tac antigen on activated human T cells by anti-Tac monoclonal antibody. J Immunol (1982) 1.19
Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int (2010) 1.17
Synthesis and secretion of parathyroid hormone in vitro. Am J Med (1971) 1.17
The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. AIDS Res Hum Retroviruses (1997) 1.17
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int (2004) 1.15
Mutations of the p53 gene in adult T-cell leukemia. Blood (1992) 1.14
Physiological and pathological variations of plasma angiotensin II in man. Correlation with renin activity and sodium balance. Circ Res (1969) 1.14
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J Virol (1985) 1.14
Differences in ankle joint complex range of motion as a function of age. Foot Ankle (1993) 1.14
Plasma calcium and parathyroid hormone responses to EDTA infusion in the cow. Am J Physiol (1967) 1.13
Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int (2006) 1.12
Variation in the clinical courses of adult T-cell leukemia. Cancer (1985) 1.11
Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med (1988) 1.10
Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. Endocrinology (1971) 1.09
Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med (1973) 1.09
Ectopic production of parathyroid hormone by carcinoma of the breast. N Engl J Med (1971) 1.08
Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors. Jpn J Cancer Res (1987) 1.08
Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab (1990) 1.07
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density. Bone (2010) 1.07
Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol (1988) 1.07
Structural basis of biological and immunological activity of parathyroid hormone. Proc Natl Acad Sci U S A (1965) 1.07
Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells. J Clin Invest (1983) 1.07
Thyroid cancer following exposure to radioactive iodine. Rev Endocr Metab Disord (2000) 1.06
Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood (1988) 1.06
The successful transplantation of frozen parathyroid tissue in man. Surgery (1977) 1.05